罕见病知识库 RareSeen

无脉络膜症

Choroideremia

定义 英文原文(暂无中文)

Choroideremia (CHM) is an X-linked chorioretinal dystrophy characterized by progressive degeneration of the choroid, retinal pigment epithelium (RPE) and retina.

别名

脉络膜毯层营养不良

基本事实

遗传方式
X 连锁隐性
发病年龄
青少年期、成年期、儿童期
患病率
1-9 / 100 000(Europe)

相关基因 1

基因名称关联类型
CHMCHM Rab escort proteinDisease-causing germline mutation(s) in

临床表型 15

极常见 99–80%5

  • 视网膜电图异常 HP:0000512
  • 视网膜色素异常 HP:0007703
  • 近视 HP:0000545
  • 夜盲症 HP:0000662
  • 视觉障碍 HP:0000505

常见 79–30%4

  • 无脉络膜症 HP:0001139
  • 周边性视野狭窄 HP:0001133
  • 周边视野缺失 HP:0007994
  • 进行性视力下降 HP:0000529

偶见 29–5%6

  • 眼底自发荧光成像异常 HP:0030602
  • 脉络膜视网膜萎缩 HP:0000533
  • 脉络膜新生血管 HP:0011506
  • 色觉缺陷 HP:0000551
  • 黄斑水肿 HP:0040049
  • 后囊下白内障 HP:0007787

近两年的全球研究 286L2

2024/08 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。

  • 2026-08
    Choroidal Caverns in Choroideremia
    Retina (Philadelphia, Pa.) · DOI · Europe PMC
  • 2026-07
    Classification of Inherited Retinal Diseases Using Artificial Intelligence Models for Fundus Autofluorescence and Ultrawide Retinal Images
    Journal of ophthalmology · DOI · Europe PMC
  • 2026-07
    Beyond innovation: why rare disease gene therapy needs a reset
    Expert opinion on biological therapy · DOI · Europe PMC
  • 2026-07
    Correction: Raeker et al. Reduced Retinal Pigment Epithelial Autophagy Due to Loss of Rab12 Prenylation in a Human iPSC-RPE Model of Choroideremia. <i>Cells</i> 2024, <i>13</i>, 1068
    Cells · DOI · Europe PMC
  • 2026-06
    Atypical choroideremia with distinctive fundus manifestations: a case report and literature review
    International journal of ophthalmology · DOI · Europe PMC
  • 2026-06
    Gene therapy in patients with choroideremia: a meta-analysis of clinical trials
    Graefe's archive for clinical and experimental ophthalmology = Albrech · DOI · Europe PMC
  • 2026-06开放获取
    Engineered tRNA reduces vision loss in a mouse model of Leber congenital amaurosis
    Signal transduction and targeted therapy · DOI · Europe PMC
  • 2026-06病例报告开放获取
    Refractory nail lichen planus treated successfully with the Janus kinase 1 inhibitor abrocitinib: A case report
    The Journal of international medical research · DOI · Europe PMC
  • 2026-06开放获取
    Directional Analysis of Residual RPE Area Loss in the Natural History of Choroideremia
    Investigative ophthalmology & visual science · DOI · Europe PMC
  • 2026-06开放获取
    Comparative Analysis of Retinal Structure and Function in Female Carriers of Choroideremia and X-Linked Retinitis Pigmentosa
    Translational vision science & technology · DOI · Europe PMC
  • 2026-05开放获取
    Optimising POU3F4 variant interpretation through gene-specific evidence in X-linked hearing loss
    EBioMedicine · DOI · Europe PMC
  • 2026-05综述开放获取
    The impact of X chromosome inactivation on human health
    Frontiers in genetics · DOI · Europe PMC
  • 2026-05
    mRNA delivery to the retina restores REP1 function in choroideremia
    Molecular therapy. Advances · DOI · Europe PMC
  • 2026-05综述开放获取
    Precision Medicine in Inherited Retinal Disease: Advances, Challenges, and Future Directions
    Journal of personalized medicine · DOI · Europe PMC
  • 2026-05综述开放获取
    Quality of Life in Patients with Posterior Segment Eye Diseases
    Journal of ophthalmic & vision research · DOI · Europe PMC
  • 2026-05病例报告
    Anatomic and Functional Recovery Following Surgical Repair of Full-Thickness Macular Hole in Choroideremia
    Journal of vitreoretinal diseases · DOI · Europe PMC
  • 2026-05开放获取
    Expanding the Genotypic Landscape of Congenital Stationary Night Blindness in an Ethnically Diverse Canadian Population
    Human mutation · DOI · Europe PMC
  • 2026-05开放获取
    Efficacy and safety of AAV-mediated gene therapy for choroideremia: a systematic review and meta-analysis
    EClinicalMedicine · DOI · Europe PMC
  • 2026-05开放获取
    Disease and Participant-Related Correlates of Genetic Testing Completion for Hereditary Eye Disorders in a Cohort of over 1400 Patients
    Ophthalmology science · DOI · Europe PMC
  • 2026-05综述
    Modalities of vision restoration in optic neuropathies and retinal disease
    Progress in retinal and eye research · DOI · Europe PMC

境外已获批用于本病的药物 0L2

欧盟与美国均未检索到已获批用于本病的药物。

已获孤儿药资格、尚未获批的在研药物(5 项)

孤儿药资格只是一种监管身份——它意味着监管机构认可这是罕见病用药并给予研发激励,不代表这个药已被证明有效,也不代表将来一定能上市。绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。

  • adeno-associated viral vector serotype 2 containing the human CHM gene欧盟2014-06-04
    Treatment of choroideraemia
    官方记录
  • adeno-associated viral vector serotype 5 containing the human CHM gene欧盟2015-04-24
    Treatment of choroideraemia
    官方记录
  • aadeno-associated viral vector, serotype 2, containing the human choro美国2013-09-12
    Treatment of choroideremia due to mutations in the human choroideremia gene (CHM)
    官方记录
  • adeno-associated viral vector serotype 2 containing the human Rab esco美国2014-11-05
    Treatment of choroideremia
    官方记录
  • adeno-associated virus (AAV2) capsid variant carrying a transgene enco美国2017-10-12
    Treatment of choroideremia (CHM)
    官方记录

数据来自欧洲药品管理局(EMA)的药品与孤儿药资格公开导出表,以及美国 FDA 孤儿药资格数据库。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。

中国境外的在招试验 4L2

这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。

美国3比利时1

共 4 项。

  • 招募中NCT06375239
    Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
    观察性 · 2024/04/05Ray Therapeutics, Inc.
    美国
  • 招募中NCT07377162
    HYPER MIND - Hyperoxia Effects on Cerebral Hemodynamics
    不适用 · 干预性 · 2024/01/01Erasme University Hospital
    比利时
  • 招募中NCT02435940
    Inherited Retinal Degenerative Disease Registry
    观察性 · 2014/06Foundation Fighting Blindness
    美国
  • 招募中NCT01866371
    High Resolution Retinal Imaging
    观察性 · 2013/05University of Pennsylvania
    美国

外部标识与链接

发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号

本页数据来源

  • 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
  • 中文病名:Orphanet 中文包,冻结于 2020-06-01
  • 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)